Next Article in Journal
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
Previous Article in Journal
Noninvasive and Convenient Screening of Metabolic Syndrome Using the Controlled Attenuation Parameter Technology: An Evaluation Based on Self-Paid Health Examination Participants
 
 
Article

Article Versions Notes

J. Clin. Med. 2019, 8(11), 1776; https://doi.org/10.3390/jcm8111776
Action Date Notes Link
article xml file uploaded 24 October 2019 15:38 CEST Original file -
article pdf uploaded. 24 October 2019 15:38 CEST Version of Record https://www.mdpi.com/2077-0383/8/11/1776/pdf-vor
article supplementary file uploaded. 24 October 2019 15:38 CEST - https://www.mdpi.com/2077-0383/8/11/1776#supplementary
article xml file uploaded 31 October 2019 10:31 CET Update -
article xml uploaded. 31 October 2019 10:31 CET Update https://www.mdpi.com/2077-0383/8/11/1776/xml
article pdf uploaded. 31 October 2019 10:31 CET Updated version of record https://www.mdpi.com/2077-0383/8/11/1776/pdf
article supplementary file uploaded. 31 October 2019 10:31 CET - https://www.mdpi.com/2077-0383/8/11/1776#supplementary
article html file updated 31 October 2019 10:32 CET Original file -
article html file updated 29 November 2019 12:02 CET Update -
article html file updated 14 February 2020 03:43 CET Update -
article html file updated 20 July 2022 00:58 CEST Update https://www.mdpi.com/2077-0383/8/11/1776/html
Back to TopTop